CGON Insider Trading Activity and SEC Form 4 Filings
CGON insider trading summary
Over the past 12 months, insiders at CG Oncology, Inc. (CGON) reported 13 sales worth $3.2M by 2 insiders and 1 open-market purchase worth $24.8M by 1 insider on SEC Form 4. Net insider buying was $21.6M.
Latest CGON insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Leonard E Post | Insider | Sell | $31K (500 @ $61.65) |
| Oct 15, 2026 | Leonard E Post | Insider | Sell | $31K (500 @ $62.48) |
| Sep 15, 2026 | Leonard E Post | Insider | Sell | $73K (1,000 @ $72.98) |
| Jul 15, 2026 | Leonard E Post | Insider | Sell | $71K (1,000 @ $71.17) |
| Jul 10, 2026 | James Mulay | Insider | Sell | $1.8M (24,165 @ $75.16) |
| Jun 25, 2026 | Brian Guan-Chyun Liu | Insider | Buy | $24.8M (371,085 @ $66.87) |
| Jun 22, 2026 | Leonard E Post | Insider | Sell | $325K (5,000 @ $65.00) |
| Jun 15, 2026 | James Mulay | Insider | Sell | $39K (654 @ $60.12) |
| Jun 15, 2026 | James Mulay | Insider | Sell | $79K (1,310 @ $60.12) |
| Mar 16, 2026 | James Mulay | Insider | Sell | $42K (654 @ $63.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.